This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International

Book Now! Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Jishna Ganguly
Scientist at GSK


Jishna Ganguly is a scientist in the CHO Mammalian Expression Technology Centre of Excellence (MET CoE) team within Drug Substance group at GSK Vaccines, Rockville. She is experienced in CHO-based cell line development and associated workflows, and has led several recombinant protein antigen expression projects in recent years.

Currently she is attempting to incorporate a rapid high-throughput clone selection and screening strategy into GSK’s cell line development workflows, that will reduce labor and cost inputs, contamination and the potential for human error.

Jishna has an MA in Cell and Microbial Biology from Catholic University of America and a B.Tech degree in Biotechnology from West Bengal University of Technology, India. Prior to her graduate studies, she worked as a research executive improving the expression of biotherapeutic proteins in the upstream process development team at Hospira (now Pfizer) in Chennai, India.

Agenda Sessions

  • Implementing Beacon optofluidic technology for accelerated cell line development for complex subunit Vaccine candidates